Cancer Research UK, Pangaea Biotech deal

Pangaea and Cancer Research UK’s commercialization and development arm, Cancer Research Technology (CRT), partnered to develop CRT’s p21 protein (Cdc42 Rac)-activated kinase (PAK) inhibitors for cance...